Form 4: AdaptHealth Director Susan Weaver Reports Acquisition of 21,346 Shares

AdaptHealth Corp. Director Susan T. Weaver reported the acquisition of 21,346 shares of common stock on June 26, 2025, increasing her direct beneficial ownership to 94,818 shares.

Summary

• Susan T. Weaver, a Director of AdaptHealth Corp. (AHCO), acquired 21,346 shares of common stock.
• The transaction occurred on June 26, 2025, with a reported price of $0 per share, indicating a grant or award rather than a cash purchase.
• Following this acquisition, Ms. Weaver's direct beneficial ownership of AdaptHealth common stock increased to 94,818 shares.
• A Power of Attorney was executed on June 30, 2025, by Dr. Susan Weaver, appointing Richard Rew and Shannone Raybon as attorneys-in-fact to handle her SEC filings, including Forms 3, 4, 5, Schedules 13D, 13G, and Forms 144.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. A director acquiring shares (even if a grant) can be seen as a positive signal of confidence, but it's a routine regulatory filing without significant new financial information.

Positives

• Increased insider ownership by a director, which can signal confidence in the company's future.
• The acquisition was at a $0 price, suggesting it was likely a compensation grant (e.g., RSU vesting), aligning director incentives with shareholder value.

Future Outlook

NA

Industry Context

This is a standard insider transaction report for a healthcare company, specifically in the home medical equipment and respiratory care sector. Such filings are routine disclosures for public companies.

Comparison to Industry Standards

• This is a standard Form 4 filing, which is a regulatory requirement for insiders.
• The acquisition of shares at $0 price is common for equity compensation plans for directors across various industries, including healthcare.
• No specific comparable companies or projects are mentioned in the document itself.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased director ownership may be viewed positively as it aligns management interests with shareholder interests. Provides transparency regarding insider holdings.
• Regulatory Bodies: Ensures compliance with Section 16(a) of the Securities Exchange Act of 1934, providing transparency on insider transactions.

Next Steps

• Susan T. Weaver will continue to file required SEC reports (Forms 3, 4, 5, Schedules 13D, 13G, Forms 144) as long as she is subject to Section 13 or 16 of the Exchange Act.

Key Dates

Keywords

AdaptHealth Corp, AHCO, Susan Weaver, Director, Insider Trading, Form 4, Stock Acquisition, Common Stock, Beneficial Ownership, SEC Filing, Corporate Governance, Equity Compensation